Clinical trial
S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
NCT00217620 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00217620 |
|---|---|
| Title | S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas |
| Official title | Phase II Trial of BAY-9006 (NSC #724772) in Advanced Soft Tissue Sarcomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | sorafenib |
| Enrollment | 51 |
| Start date | Mar 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Sep 1, 2012 |
| First posted | Sep 22, 2005 |
| Last update posted | May 15, 2014 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: